Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

7 Cryptos to Watch as ETF Mania Bolsters the Blockchain

With the U.S. Securities and Exchange Commission (SEC) facing a Jan. 10 deadline for one of the applications associated with a spot-virtual currency exchange-traded fund,…

7 Hot Stocks That Could Fly if the Fed Goes Dovish in 2024

Based on the latest economic print, the Federal Reserve expects a shift in monetary policy, which undergirds certain stocks for a dovish Fed. It really…

Sleeper Hits: 3 Stocks on the Brink of Explosive Returns

When I think about sleeper stocks, my mind goes to fictional character Freddy Krueger. Stay with me for a second. As you may know from…

3 Monthly Dividend Stocks for Consistent Passive Income

While passive income offers an important cog in your portfolio, the enterprises that provide mostly do so on a quarterly basis, thus drawing intrigue for…

7 Overlooked Small-Cap Stocks to Keep On Your Radar

It’s an obvious risk factor: overlooked small-cap stocks offer tremendous upside potential but in exchange for the likelihood of severe volatility. Imagine you’re a couch…

7 Blue-Chip Stocks to Snap Up at Can’t-Miss Prices

With the overall surge in the broader equity indices last year, you might think that cheap blue-chip stocks would be difficult to find. To be…

TWLO Stock Jumps as Twilio Announces CEO Transition

Although Twilio co-founder Jeff Lawson will resign from the CEO role, that will likely not satisfy activist criticism of TWLO stock.

Why Is Ambrx Biopharma (AMAM) Stock Up 100% Today?

With Johnson & Johnson buying out Ambrx Biopharma, the win-win deal boosted AMAM stock while better positioning J&J’s oncology unit.

The 3 Hottest Wearable Technology Stocks to Watch in 2024

With consumers increasingly demanding the ultimate in convenience, these are the wearable technology stocks to consider.

Solar Surge: 3 Stocks to Buy BEFORE the Industry Rebounds

Undeniably, one of the worst-hit sectors overall last year was solar stocks. So, why bother even considering this embattled sector? Basically, the fundamental narrative may…